STOCK TITAN

Celestica’s Newest U.S. Facility Certified to ISO 13485 for Medical Device Manufacturing

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Neutral)
Tags

Celestica’s Minnesota-based subsidiary, AbelConn Electronics, expands capabilities to bring in-region design and manufacturing services to healthcare customers

TORONTO, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Celestica Inc. (NYSE, TSX: CLS), a leader in design, manufacturing, and supply chain solutions for the world’s most innovative companies, today announced its AbelConn Electronics facility in Maple Grove, MN, has earned ISO 13485:2016 certification for medical device production. The certification expands Celestica’s global expertise in design and manufacturing to drive market-leading quality and regulatory compliance for our global healthcare customers.

“Earning ISO 13485 certification enables us to provide healthcare customers, especially in the United States and throughout North America, with quick-turn manufacturing and delivery capabilities, improving their resilience to supply chain disruptions with an in-region solution,” said Kevin Walsh, Vice President, Celestica HealthTech. “The AbelConn team has extensive experience in serving highly regulated industries like defense and aerospace, and they bring that same level of rigor and quality control practices to support our HealthTech customers.”

The Maple Grove facility is the newest addition to Celestica’s global HealthTech network of ISO 13485-certified facilities for medical device production around the world. Follow this link to view a tour of the state-of-the-art facility.

About Celestica

Celestica enables the world's best brands. Through our recognized customer-centric approach, we partner with leading companies in aerospace and defense, communications, enterprise, healthtech, industrial, capital equipment, and energy to deliver solutions for their most complex challenges. As a leader in design, manufacturing, hardware platform, and supply chain solutions, Celestica brings global expertise and insight at every stage of product development - from the drawing board to full-scale production and after-market services. With talented teams across North America, Europe, and Asia, we imagine, develop and deliver a better future with our customers.

For further information on Celestica, visit www.celestica.com. Our securities filings can be accessed at www.sedar.com and www.sec.gov.

Contacts:
Celestica Global Communications: (416) 448-2200, media@celestica.com


Celestica, Inc.

NYSE:CLS

CLS Rankings

CLS Latest News

CLS Stock Data

10.85B
115.56M
1.01%
80.1%
2.93%
Electronic Components
Technology
Link
United States of America
Toronto